HomeComparePMD vs MO

PMD vs MO: Dividend Comparison 2026

PMD yields 10.49% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MO wins by $56.2K in total portfolio value· pulled ahead in Year 5
10 years
PMD
PMD
● Live price
10.49%
Share price
$2.67
Annual div
$0.28
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.5K
Annual income
$1.12
Full PMD calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — PMD vs MO

📍 MO pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPMDMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PMD + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PMD pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PMD
Annual income on $10K today (after 15% tax)
$891.39/yr
After 10yr DRIP, annual income (after tax)
$0.95/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, MO beats the other by $24,622.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PMD + MO for your $10,000?

PMD: 50%MO: 50%
100% MO50/50100% PMD
Portfolio after 10yr
$49.6K
Annual income
$14,484.83/yr
Blended yield
29.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

PMD
No analyst data
Altman Z
1.7
Piotroski
4/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PMD buys
0
MO buys
11
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$MO▲ Buy$1,000 - $15,0002025-08-04
Sheri Biggs🏢 House$MO▼ Sell$1,001 - $15,0002025-03-19
Pete Sessions🏢 House$MO▼ Sell$1,001 - $15,0002024-09-10
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-03-20
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-02-13
Virginia Foxx🏢 House$MO▼ Sell$1,001 - $15,0002024-01-16
Virginia Foxx🏢 House$MO▲ Buy$1,001 - $15,0002024-01-11
Ro Khanna🏢 House$MO▼ Sell$1,001 - $15,0002024-01-10
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-01-10
Virginia Foxx🏢 House$MO▼ Sell$15,001 - $50,0002024-01-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPMDMO
Forward yield10.49%6.27%
Annual dividend / share$0.28$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%22.6%
Portfolio after 10y$21.5K$77.7K
Annual income after 10y$1.12$28,968.54
Total dividends collected$1.1K$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: PMD vs MO ($10,000, DRIP)

YearPMD PortfolioPMD Income/yrMO PortfolioMO Income/yrGap
1$11,224$524.34$10,558$768.31+$666.00PMD
2$12,285$275.02$11,352$1,015.87+$933.00PMD
3$13,286$140.66$12,482$1,367.86+$804.00PMD
4$14,287$71.08$14,103$1,883.39+$184.00PMD
5← crossover$15,323$35.72$16,472$2,664.91$1.1KMO
6$16,413$17.90$20,024$3,897.79$3.6KMO
7$17,571$8.96$25,537$5,933.74$8.0KMO
8$18,805$4.48$34,478$9,476.77$15.7KMO
9$20,124$2.24$49,776$16,022.63$29.7KMO
10$21,534$1.12$77,699$28,968.54$56.2KMO

PMD vs MO: Complete Analysis 2026

PMDStock

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.

Full PMD Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this PMD vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PMD vs SCHDPMD vs JEPIPMD vs OPMD vs KOPMD vs MAINPMD vs PMPMD vs BTIPMD vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.